Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Psychology, Uppsala University, Uppsala, Sweden.
BMC Med. 2024 Sep 19;22(1):403. doi: 10.1186/s12916-024-03569-8.
Intrusive memories of psychologically traumatic events bring distress both sub-clinically and clinically. This parallel-group, two-arm randomised controlled trial evaluated the effect of a brief behavioural intervention on reducing intrusive memories in frontline healthcare workers exposed to traumatic events during the COVID-19 pandemic.
Participants with at least two intrusive memories of work-related trauma in the week before recruitment were randomised 1:1 to an imagery-competing task intervention (n = 73) or attention-based control task (n = 71). The number of intrusive memories was assessed at baseline and 5 weeks after the guided session (primary endpoint).
The intervention significantly reduced intrusive memory frequency compared with control [intervention Mdn = 1.0 (IQR = 0-3), control Mdn = 5.0 (IQR = 1-17); p < 0.0001, IRR = 0.30; 95% CI = 0.17-0.53] and led to fewer post-traumatic stress-related symptoms at 1, 3 and 6 month follow-ups (secondary endpoints). Participants and statisticians were blinded to allocation. Adverse events data were acquired throughout the trial, demonstrating safety. There was high adherence and low attrition.
This brief, single-symptom, repeatable digital intervention for subclinical-to-clinical samples after trauma allows scalability, taking a preventing-to-treating approach after trauma.
2020-07-06, ClinicalTrials.gov identifier: NCT04460014.
心理创伤事件的侵入性记忆会给临床和亚临床患者带来痛苦。这项平行组、双臂随机对照试验评估了一种简短的行为干预对减少在 COVID-19 大流行期间接触创伤性事件的一线医护人员侵入性记忆的效果。
在招募前一周至少有两次与工作相关创伤的侵入性记忆的参与者被随机分配到意象竞争任务干预组(n=73)或基于注意力的对照组(n=71)。在基线和引导疗程后 5 周评估侵入性记忆的次数(主要终点)。
与对照组相比,干预组显著降低了侵入性记忆频率[干预组中位数=1.0(IQR=0-3),对照组中位数=5.0(IQR=1-17);p<0.0001,IRR=0.30;95%CI=0.17-0.53],并在 1、3 和 6 个月随访时导致较少的创伤后应激相关症状(次要终点)。参与者和统计人员对分组情况不知情。在整个试验过程中收集了不良事件数据,证明了该方法的安全性。该方法具有较高的依从性和较低的流失率。
对于创伤后亚临床至临床样本,这种简短、单次症状、可重复的数字干预措施可以实现可扩展性,在创伤后采取预防治疗方法。
2020-07-06,ClinicalTrials.gov 标识符:NCT04460014。